{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:59:35Z","timestamp":1793192375533,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US Office of Research Integrity"},{"name":"Oklahoma Center for Advancement of Science and Technology"},{"name":"Internal grants from Oklahoma State University Center for Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24290-3","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:03:13Z","timestamp":1763474593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systematic review with cross sectional comparative analysis identifies adverse event reporting discrepancies between ClinicalTrials.gov and published glaucoma randomized controlled trials"],"prefix":"10.1038","volume":"15","author":[{"given":"Ahmed","family":"Elghzali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahad","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"24290_CR1","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators & Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob. Health 9, e144\u2013e160 (2021)."},{"key":"24290_CR2","first-page":"e11686","volume":"12","author":"K Allison","year":"2020","unstructured":"Allison, K., Patel, D. & Alabi, O. Epidemiology of glaucoma: The past, present, and predictions for the future. Cureus 12, e11686 (2020).","journal-title":"Cureus"},{"key":"24290_CR3","doi-asserted-by":"publisher","first-page":"e0137913","DOI":"10.1371\/journal.pone.0137913","volume":"10","author":"S Thomas","year":"2015","unstructured":"Thomas, S., Hodge, W. & Malvankar-Mehta, M. The cost-effectiveness analysis of teleglaucoma screening device. PLoS ONE 10, e0137913 (2015).","journal-title":"PLoS ONE"},{"key":"24290_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","volume":"141","author":"JPA Ioannidis","year":"2004","unstructured":"Ioannidis, J. P. A. et al. Better reporting of harms in randomized trials: An extension of the CONSORT statement. Ann. Intern. Med. 141, 781\u2013788 (2004).","journal-title":"Ann. Intern. Med."},{"key":"24290_CR5","doi-asserted-by":"publisher","first-page":"f7668","DOI":"10.1136\/bmj.f7668","volume":"348","author":"L Zorzela","year":"2014","unstructured":"Zorzela, L. et al. Quality of reporting in systematic reviews of adverse events: Systematic review. BMJ 348, f7668 (2014).","journal-title":"BMJ"},{"key":"24290_CR6","doi-asserted-by":"publisher","first-page":"g6501","DOI":"10.1136\/bmj.g6501","volume":"349","author":"P Saini","year":"2014","unstructured":"Saini, P. et al. Selective reporting bias of harm outcomes within studies: Findings from a cohort of systematic reviews. BMJ 349, g6501 (2014).","journal-title":"BMJ"},{"key":"24290_CR7","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1200\/JCO.2013.49.3981","volume":"31","author":"J P\u00e9ron","year":"2013","unstructured":"P\u00e9ron, J., Maillet, D., Gan, H. K., Chen, E. X. & You, B. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: A systematic review. J. Clin. Oncol. 31, 3957\u20133963 (2013).","journal-title":"J. Clin. Oncol."},{"key":"24290_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","volume":"32","author":"S Sivendran","year":"2014","unstructured":"Sivendran, S. et al. Adverse event reporting in cancer clinical trial publications. J. Clin. Oncol. 32, 83\u201389 (2014).","journal-title":"J. Clin. Oncol."},{"key":"24290_CR9","doi-asserted-by":"publisher","first-page":"e003436","DOI":"10.1136\/bmjopen-2013-003436","volume":"3","author":"A Hodkinson","year":"2013","unstructured":"Hodkinson, A., Kirkham, J. J., Tudur-Smith, C. & Gamble, C. Reporting of harms data in RCTs: A systematic review of empirical assessments against the CONSORT harms extension. BMJ Open 3, e003436 (2013).","journal-title":"BMJ Open"},{"key":"24290_CR10","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.pain.2012.08.009","volume":"153","author":"SM Smith","year":"2012","unstructured":"Smith, S. M. et al. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review. Pain 153, 2415\u20132421 (2012).","journal-title":"Pain"},{"key":"24290_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","volume":"169","author":"I Pitrou","year":"2009","unstructured":"Pitrou, I., Boutron, I., Ahmad, N. & Ravaud, P. Reporting of safety results in published reports of randomized controlled trials. Arch. Intern. Med. 169, 1756\u20131761 (2009).","journal-title":"Arch. Intern. Med."},{"key":"24290_CR12","unstructured":"Health and Human Services Department. Clinical Trials Registration and Results Information Submission. Federal Register Preprint at https:\/\/www.federalregister.gov\/documents\/2016\/09\/21\/2016-22129\/clinical-trials-registration-and-results-information-submission."},{"key":"24290_CR13","unstructured":"ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/policy\/fdaaa-801-final-rule."},{"key":"24290_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12916-015-0430-4","volume":"13","author":"E Tang","year":"2015","unstructured":"Tang, E., Ravaud, P., Riveros, C., Perrodeau, E. & Dechartres, A. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles. BMC Med. 13, 189 (2015).","journal-title":"BMC Med."},{"key":"24290_CR15","doi-asserted-by":"publisher","first-page":"e1001566","DOI":"10.1371\/journal.pmed.1001566","volume":"10","author":"C Riveros","year":"2013","unstructured":"Riveros, C. et al. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. Plos Med. 10, e1001566 (2013).","journal-title":"Plos Med."},{"key":"24290_CR16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7326\/L14-5022","volume":"161","author":"JE Becker","year":"2014","unstructured":"Becker, J. E. & Ross, J. S. Reporting discrepancies between the clinicaltrials.gov results database and peer-reviewed publications. Ann. Intern. Med. 161, 760 (2014).","journal-title":"Ann. Intern. Med."},{"key":"24290_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/M13-0480","volume":"160","author":"DM Hartung","year":"2014","unstructured":"Hartung, D. M. et al. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications. Ann. Intern. Med. 160, 477\u2013483 (2014).","journal-title":"Ann. Intern. Med."},{"key":"24290_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1186\/s13063-020-04603-9","volume":"21","author":"R Talebi","year":"2020","unstructured":"Talebi, R., Redberg, R. F. & Ross, J. S. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: One decade after FDAAA. Trials 21, 675 (2020).","journal-title":"Trials"},{"key":"24290_CR19","doi-asserted-by":"publisher","first-page":"e1002127","DOI":"10.1371\/journal.pmed.1002127","volume":"13","author":"S Golder","year":"2016","unstructured":"Golder, S., Loke, Y. K., Wright, K. & Norman, G. Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. Plos Med. 13, e1002127 (2016).","journal-title":"Plos Med."},{"key":"24290_CR20","doi-asserted-by":"publisher","first-page":"e005535","DOI":"10.1136\/bmjopen-2014-005535","volume":"4","author":"S Hughes","year":"2014","unstructured":"Hughes, S., Cohen, D. & Jaggi, R. Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: A cross-sectional study. BMJ Open 4, e005535 (2014).","journal-title":"BMJ Open"},{"key":"24290_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jclinepi.2015.07.007","volume":"70","author":"S Prani\u0107","year":"2016","unstructured":"Prani\u0107, S. & Maru\u0161i\u0107, A. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles. J. Clin. Epidemiol. 70, 26\u201337 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"24290_CR22","doi-asserted-by":"publisher","first-page":"f3981","DOI":"10.1136\/bmj.f3981","volume":"346","author":"MA Rodgers","year":"2013","unstructured":"Rodgers, M. A. et al. Reporting of industry funded study outcome data: Comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion. BMJ 346, f3981 (2013).","journal-title":"BMJ"},{"key":"24290_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12874-022-01730-6","volume":"22","author":"I Paladin","year":"2022","unstructured":"Paladin, I. & Prani\u0107, S. M. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study. BMC Med. Res. Methodol. 22, 262 (2022).","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"24290_CR24","doi-asserted-by":"publisher","first-page":"27762","DOI":"10.1038\/s41598-024-79394-z","volume":"14","author":"A Kre\u0161o","year":"2024","unstructured":"Kre\u0161o, A., Grahovac, M., Znaor, L. & Maru\u0161i\u0107, A. Safety reporting in trials on glaucoma interventions registered in ClinicalTrials.gov and corresponding publications. Sci. Rep. 14(1), 27762 (2024).","journal-title":"Sci. Rep."},{"key":"24290_CR25","unstructured":"PRISMA 2020 statement \u2014. PRISMA statement https:\/\/www.prisma-statement.org\/prisma-2020."},{"key":"24290_CR26","unstructured":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/."},{"key":"24290_CR27","doi-asserted-by":"publisher","unstructured":"Vassar, M., Khan, S., Khan, A., Elghzali, A. & Chaudhry, M. Adverse Event Reporting Discrepancies in glaucoma clinical trials. Preprint at https:\/\/doi.org\/10.17605\/OSF.IO\/MXSH4 (2025).","DOI":"10.17605\/OSF.IO\/MXSH4"},{"key":"24290_CR28","unstructured":"STROBE - Strengthening the reporting of observational studies in epidemiology. STROBE https:\/\/www.strobe-statement.org\/."},{"key":"24290_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijnurstu.2014.09.006","volume":"52","author":"TA Lang","year":"2015","unstructured":"Lang, T. A. & Altman, D. Basic statistical reporting for articles published in biomedical journals: The \u2018statistical analyses and methods in the published literature\u2019 or the SAMPL guidelines. Int. J. Nurs. Stud. 52, 5\u20139 (2015).","journal-title":"Int. J. Nurs. Stud."},{"key":"24290_CR30","doi-asserted-by":"publisher","first-page":"e031138","DOI":"10.1136\/bmjopen-2019-031138","volume":"9","author":"EK Wong","year":"2019","unstructured":"Wong, E. K. et al. Selective reporting bias in randomised controlled trials from two network meta-analyses: Comparison of clinical trial registrations and their respective publications. BMJ Open 9, e031138 (2019).","journal-title":"BMJ Open"},{"key":"24290_CR31","doi-asserted-by":"publisher","first-page":"d8141","DOI":"10.1136\/bmj.d8141","volume":"344","author":"B Wieseler","year":"2012","unstructured":"Wieseler, B., Kerekes, M. F., Vervoelgyi, V., McGauran, N. & Kaiser, T. Impact of document type on reporting quality of clinical drug trials: A comparison of registry reports, clinical study reports, and journal publications. BMJ 344, d8141 (2012).","journal-title":"BMJ"},{"key":"24290_CR32","doi-asserted-by":"publisher","first-page":"e1001526","DOI":"10.1371\/journal.pmed.1001526","volume":"10","author":"B Wieseler","year":"2013","unstructured":"Wieseler, B. et al. Completeness of reporting of patient-relevant clinical trial outcomes: Comparison of unpublished clinical study reports with publicly available data. Plos Med. 10, e1001526 (2013).","journal-title":"Plos Med."},{"key":"24290_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.euroneuro.2010.10.005","volume":"21","author":"T Mattila","year":"2011","unstructured":"Mattila, T. et al. Insomnia medication: Do published studies reflect the complete picture of efficacy and safety?. Eur. Neuropsychopharmacol. 21, 500\u2013507 (2011).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"24290_CR34","doi-asserted-by":"publisher","first-page":"h796","DOI":"10.1136\/bmj.h796","volume":"350","author":"M K\u00f6hler","year":"2015","unstructured":"K\u00f6hler, M. et al. Information on new drugs at market entry: Retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. BMJ 350, h796 (2015).","journal-title":"BMJ"},{"key":"24290_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/bmj.280.6217.833","volume":"280","author":"E Hemminki","year":"1980","unstructured":"Hemminki, E. Study of information submitted by drug companies to licensing authorities. Br. Med. J. 280, 833\u2013836 (1980).","journal-title":"Br. Med. J."},{"key":"24290_CR36","doi-asserted-by":"publisher","first-page":"g3510","DOI":"10.1136\/bmj.g3510","volume":"348","author":"E Maund","year":"2014","unstructured":"Maund, E. et al. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: Comparison of clinical study reports, trial registries, and publications. BMJ 348, g3510 (2014).","journal-title":"BMJ"},{"key":"24290_CR37","doi-asserted-by":"publisher","first-page":"h4320","DOI":"10.1136\/bmj.h4320","volume":"351","author":"J Le Noury","year":"2015","unstructured":"Le Noury, J. et al. Restoring study 329: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351, h4320 (2015).","journal-title":"BMJ"},{"key":"24290_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13063-016-1327-z","volume":"17","author":"A Hodkinson","year":"2016","unstructured":"Hodkinson, A., Gamble, C. & Smith, C. T. Reporting of harms outcomes: A comparison of journal publications with unpublished clinical study reports of orlistat trials. Trials 17, 207 (2016).","journal-title":"Trials"},{"key":"24290_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/IJG.0000000000002262","volume":"33","author":"R Michael","year":"2024","unstructured":"Michael, R., Zhang, H., McIntyre, S., Cape, L. & Toren, A. Examining bias in published surgical glaucoma clinical trials. J. Glaucoma 33, 8\u201314 (2024).","journal-title":"J. Glaucoma"},{"key":"24290_CR40","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","volume":"340","author":"JJ Kirkham","year":"2010","unstructured":"Kirkham, J. J. et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340, c365 (2010).","journal-title":"BMJ"},{"key":"24290_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13643-016-0289-2","volume":"5","author":"MJ Page","year":"2016","unstructured":"Page, M. J. & Higgins, J. P. T. Rethinking the assessment of risk of bias due to selective reporting: A cross-sectional study. Syst. Rev. 5, 108 (2016).","journal-title":"Syst. Rev."},{"key":"24290_CR42","unstructured":"Chapter 8: Assessing risk of bias in a randomized trial. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-08."},{"key":"24290_CR43","first-page":"MR000033","volume":"2","author":"A Lundh","year":"2017","unstructured":"Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B. & Bero, L. Industry sponsorship and research outcome. Cochrane Database Syst. Rev. 2, MR000033 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"24290_CR44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00134-018-5293-7","volume":"44","author":"A Lundh","year":"2018","unstructured":"Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B. & Bero, L. Industry sponsorship and research outcome: Systematic review with meta-analysis. Intensive Care Med. 44, 1603\u20131612 (2018).","journal-title":"Intensive Care Med."},{"key":"24290_CR45","doi-asserted-by":"publisher","first-page":"e2343425","DOI":"10.1001\/jamanetworkopen.2023.43425","volume":"6","author":"LM Siena","year":"2023","unstructured":"Siena, L. M., Papamanolis, L., Siebert, M. J., Bellomo, R. K. & Ioannidis, J. P. A. Industry involvement and transparency in the most cited clinical trials, 2019\u20132022. JAMA Netw. Open 6, e2343425 (2023).","journal-title":"JAMA Netw. Open"},{"key":"24290_CR46","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMe048225","volume":"351","author":"C De Angelis","year":"2004","unstructured":"De Angelis, C. et al. Clinical trial registration: A statement from the international committee of medical journal editors. N. Engl. J. Med. 351, 1250\u20131251 (2004).","journal-title":"N. Engl. J. Med."},{"key":"24290_CR47","unstructured":"Responsibility, M. International Standards for Clinical Trial Registries. https:\/\/iris.who.int\/bitstream\/handle\/10665\/274994\/9789241514743-eng.pdf."},{"key":"24290_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jclinepi.2023.04.005","volume":"158","author":"DR Junqueira","year":"2023","unstructured":"Junqueira, D. R. et al. CONSORT Harms 2022 statement, explanation, and elaboration: Updated guideline for the reporting of harms in randomized trials. J. Clin. Epidemiol. 158, 149\u2013165 (2023).","journal-title":"J. Clin. Epidemiol."},{"key":"24290_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jama.285.4.437","volume":"285","author":"JP Ioannidis","year":"2001","unstructured":"Ioannidis, J. P. & Lau, J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285, 437\u2013443 (2001).","journal-title":"JAMA"},{"key":"24290_CR50","volume-title":"6 the Revision of the Credit Derivative Definitions in the Context of the Bank Recovery and Resolution Directive","author":"G Simon","year":"2016","unstructured":"Simon, G. & Christian, M. 6 the Revision of the Credit Derivative Definitions in the Context of the Bank Recovery and Resolution Directive (Oxford University Press, 2016)."},{"key":"24290_CR51","unstructured":"Selective Reporting of Results. https:\/\/ori.hhs.gov\/selective-reporting-results."},{"key":"24290_CR52","unstructured":"Travitz, H. 3.1 Description of Research Misconduct. https:\/\/cse.memberclicks.net\/3-1-description-of-research-misconduct."},{"key":"24290_CR53","unstructured":"ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/policy\/fdaaa-801-final-rule."},{"key":"24290_CR54","unstructured":"Sociodemographic Characteristics of Adverse Event Reporting. U.S. Food and Drug Administration https:\/\/www.fda.gov\/drugs\/spotlight-cder-science\/sociodemographic-characteristics-adverse-event-reporting (2024)."},{"key":"24290_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmjqs-2020-011920","volume":"30","author":"LB Schulson","year":"2020","unstructured":"Schulson, L. B., Novack, V., Folcarelli, P. H., Stevens, J. P. & Landon, B. E. Inpatient patient safety events in vulnerable populations: A retrospective cohort study. BMJ Qual. Saf. 30, 372\u2013379 (2020).","journal-title":"BMJ Qual. Saf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24290-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:02:57Z","timestamp":1763863377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24290-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24290"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24290-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40563"}}